← All organizations

SUNHO（China）BioPharmaceutical CO., Ltd.

For profitWebsite ↗

Also known as: GUANGDONG SUNHO | SUNHO（China）BioPharmaceutical CO., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Aug 1, 2025

Timeline

2010s

Jun 1, 2017
SUNHO（China）BioPharmaceutical CO., Ltd.— Founded

2020s

May 13, 2025
docetaxel— Marketing Organization

Drugs by trial phase (15 distinct, 14 trials)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Marketed drugs (1)

docetaxel

Recent trials (14)

NCT07076095Lead sponsorPhase 2Aug 1, 2025
NCT06719479Lead sponsorPhase 2/Phase 3Jan 1, 2025
NCT06581419Lead sponsorPhase 1/Phase 2Oct 1, 2024
NCT06504732Lead sponsorPhase 2/Phase 3Jul 31, 2024
NCT06292208Lead sponsorPhase 1/Phase 2Mar 2, 2024
NCT06223841Lead sponsorPhase 1/Phase 2Mar 1, 2024
NCT06255964Lead sponsorPhase 1/Phase 2Feb 15, 2024
NCT05991583Lead sponsorPhase 1/Phase 2Jun 28, 2023
NCT05673512Lead sponsorPhase 2/Phase 3May 12, 2023
NCT05991518Lead sponsorPhase 1/Phase 2Apr 25, 2023
NCT05396339Lead sponsorPhase 1/Phase 2Jun 1, 2022
NCT05396391Lead sponsorPhase 1/Phase 2Jun 1, 2022
NCT04980690Lead sponsorPhase 1/Phase 2Oct 31, 2021
NCT04934514Lead sponsorPhase 1/Phase 2Aug 31, 2021

Details

Founded: Beijing, CN Jun 1, 2017
Last known activity: Aug 1, 2025